Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Orteq signs French deal for synthetic scaffold

This article was originally published in Clinica

Executive Summary

UK orthopaedic firm Orteq Bioengineering has signed a distribution deal with FH Orthopaedics, in a bid to increase sales of its Actifit synthetic scaffold for meniscal injury in France. The deal will allow FH (Heimsbrunn, France) to increase the coverage of Actifit, which, a spokesperson told Clinica, was only sold by Orteq in the country at a “low level” previously. Financial terms of the agreement were not disclosed. According to London-based Orteq, Actifit provides a structure for growth of new tissue, in places were damaged meniscal tissue has been surgically removed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043027

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel